Glenview Trust CO Abbott Laboratories Transaction History

Glenview Trust CO

$5.27 Billion
Q4 2024

A detailed history of Glenview Trust CO transactions in Abbott Laboratories stock. As of the latest transaction made, Glenview Trust CO holds 93,316 shares of ABT stock, worth $12.1 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

93,316

Previous 89,495 4.27%

Holding current value

$12.1 Million

Previous $10.2 Million 3.44%

% of portfolio

0.2%

Previous 0.2%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	BUY	$111.93 - $119.39 $427,684 - $456,189	3,821 Added 4.27%	93,316 $10.6 Million
Q3 2024 Nov 12, 2024	BUY	$100.07 - $118.13 $32,122 - $37,919	321 Added 0.36%	89,495 $10.2 Million
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $16,217 - $18,102	161 Added 0.18%	89,174 $9.27 Million
Q1 2024 May 14, 2024	BUY	$109.52 - $120.96 $429,756 - $474,647	3,924 Added 4.61%	89,013 $10.1 Million
Q4 2023 Feb 12, 2024	SELL	$90.19 - $110.4 $132,940 - $162,729	-1,474 Reduced 1.7%	85,089 $9.37 Million
Q3 2023 Nov 13, 2023	BUY	$95.53 - $114.62 $15,189 - $18,224	159 Added 0.18%	86,563 $8.38 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $94,833 - $105,664	941 Added 1.1%	86,404 $9.42 Million
Q1 2023 May 09, 2023	BUY	$96.86 - $114.01 $98,216 - $115,606	1,014 Added 1.2%	85,463 $8.65 Million
Q4 2022 Feb 08, 2023	BUY	$95.06 - $111.52 $43,252 - $50,741	455 Added 0.54%	84,449 $9.27 Million
Q3 2022 Nov 04, 2022	SELL	$96.76 - $112.03 $28,737 - $33,272	-297 Reduced 0.35%	83,994 $8.13 Million
Q2 2022 Aug 10, 2022	BUY	$102.07 - $123.37 $241,905 - $292,386	2,370 Added 2.89%	84,291 $9.16 Million
Q1 2022 May 11, 2022	SELL	$114.02 - $139.04 $141,270 - $172,270	-1,239 Reduced 1.49%	81,921 $9.7 Million
Q4 2021 Feb 10, 2022	BUY	$115.53 - $141.46 $446,061 - $546,177	3,861 Added 4.87%	83,160 $11.7 Million
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $262,718 - $290,643	2,252 Added 2.92%	79,299 $9.37 Million
Q2 2021 Aug 11, 2021	BUY	$105.79 - $124.53 $349,212 - $411,073	3,301 Added 4.48%	77,047 $8.93 Million
Q1 2021 May 12, 2021	SELL	$108.84 - $128.23 $244,345 - $287,876	-2,245 Reduced 2.95%	73,746 $8.84 Million
Q4 2020 Feb 02, 2021	SELL	$105.0 - $114.42 $72,030 - $78,492	-686 Reduced 0.89%	75,991 $8.32 Million
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $6,139 - $7,456	67 Added 0.09%	76,677 $8.35 Million
Q2 2020 Aug 12, 2020	SELL	$76.57 - $98.0 $255,131 - $326,536	-3,332 Reduced 4.17%	76,610 $7 Million
Q1 2020 Apr 28, 2020	SELL	$62.82 - $91.86 $212,268 - $310,394	-3,379 Reduced 4.06%	79,942 $6.31 Million
Q4 2019 Feb 06, 2020	BUY	$78.51 - $87.4 $218,964 - $243,758	2,789 Added 3.46%	83,321 $7.24 Million
Q3 2019 Nov 14, 2019	BUY	$81.84 - $88.74 $29,707 - $32,212	363 Added 0.45%	80,532 $6.74 Million
Q2 2019 Aug 08, 2019	BUY	$72.88 - $85.0 $12,243 - $14,280	168 Added 0.21%	80,169 $0
Q1 2019 May 14, 2019	SELL	$66.22 - $80.06 $114,891 - $138,904	-1,735 Reduced 2.12%	80,001 $6.4 Million
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $149,149 - $168,964	2,275 Added 2.86%	81,736 $5.91 Million
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $4.83 Million - $5.83 Million	79,461 New	79,461 $5.83 Million
Q2 2018 Aug 10, 2018	SELL	$57.57 - $63.54 $4.61 Million - $5.09 Million	-80,040 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$56.27 - $63.62 $41,808 - $47,269	-743 Reduced 0.92%	80,040 $0
Q4 2017 Feb 06, 2018	BUY	$53.68 - $57.47 $14,923 - $15,976	278 Added 0.35%	80,783 $4.61 Million
Q3 2017 Nov 07, 2017	BUY	$48.06 - $53.64 $3.87 Million - $4.32 Million	80,505	80,505 $4.3 Million

Others Institutions Holding ABT

# of Institutions

3,344

Shares Held

1.36B

Call Options Held

10.7M

Put Options Held

8.87M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $228B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenview Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Glenview Trust CO with notifications on news.

Account

Glenview Trust CO Abbott Laboratories Transaction History